Find the Perfect Plan for Your Investment Journey
G
Latest price
52 Week Range
DKK273.00 - DKK754.00
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | DKK5.92B |
EV | DKK5.60B |
Shares Outstanding | 16.31M |
Beta | 0.73 |
Analyst Rating | BUY |
Analyst Target Price | DKK750.00 |
P/E 2025E | 12.33x |
P/Revenue 2025E | 2.02x |
Revenue | 1.30% |
EPS | - |
Operating Cash Flow | -61.60% |
Free Cash Flow | - |
Revenue | 74.60% |
EPS | - |
Operating Cash Flow | 436.30% |
Free Cash Flow | - |
Gross Margin 2025E | 95.90% |
Net Profit Margin 2025E | 66.74% |
ROE 2025E | 132.40% |
ROCE 2024 | -7.85% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Gubra A/S
GUBRA
Sector
Healthcare
Industry
Biotechnology
CEO
Blou, Henrik
Employees
260
Website
www.gubra.dkIPO Date
2023-04-04
Headquarters
Hørsholm Kongevej 11B, Horsholm, Capital Region of Denmark, 2970, Denmark
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved